X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (550) 550
index medicus (428) 428
male (396) 396
animals (306) 306
pyrrolidinones - pharmacokinetics (305) 305
pharmacology & pharmacy (292) 292
female (264) 264
raltegravir potassium (261) 261
pyrrolidinones - pharmacology (241) 241
adult (228) 228
pyrrolidinones - administration & dosage (189) 189
middle aged (186) 186
hiv infections - drug therapy (181) 181
pyrrolidinones - therapeutic use (177) 177
pharmacokinetics (175) 175
rats (156) 156
pyrrolidinones - chemistry (125) 125
raltegravir (120) 120
infectious diseases (113) 113
pyrrolidinones - adverse effects (103) 103
dose-response relationship, drug (94) 94
drug interactions (93) 93
mice (82) 82
hiv (81) 81
pyrrolidinones - blood (78) 78
treatment outcome (76) 76
young adult (73) 73
microbiology (70) 70
hiv infections - virology (68) 68
hiv integrase inhibitors - pharmacokinetics (68) 68
analysis (66) 66
epilepsy (64) 64
aged (63) 63
antiviral agents (63) 63
drug therapy (63) 63
hiv-1 - drug effects (63) 63
anti-hiv agents - administration & dosage (62) 62
administration, oral (60) 60
safety (60) 60
adolescent (58) 58
rats, sprague-dawley (58) 58
anti-hiv agents - pharmacokinetics (55) 55
immunology (55) 55
anti-hiv agents - therapeutic use (54) 54
hiv integrase inhibitors - therapeutic use (54) 54
double-blind (53) 53
chemistry, medicinal (52) 52
efficacy (51) 51
brivaracetam (50) 50
therapy (50) 50
clinical neurology (49) 49
antiretroviral therapy (47) 47
area under curve (47) 47
drug therapy, combination (47) 47
pyrrolidinones - metabolism (45) 45
mk-0518 (43) 43
time factors (43) 43
drugs (42) 42
research (42) 42
virology (42) 42
hiv-1 (41) 41
in vitro techniques (41) 41
viral load (41) 41
oncology (40) 40
pharmacology (40) 40
pyrrolidinones (40) 40
structure-activity relationship (40) 40
anticonvulsants - therapeutic use (39) 39
hiv infection (39) 39
hiv integrase inhibitors - pharmacology (39) 39
toxicology (39) 39
double-blind method (38) 38
dosage and administration (37) 37
drug administration schedule (37) 37
drug resistance, viral (37) 37
hiv integrase inhibitors - administration & dosage (37) 37
levetiracetam (37) 37
plasma (37) 37
care and treatment (36) 36
half-life (35) 35
infection (35) 35
integrase inhibitor (35) 35
integrase inhibitor raltegravir (35) 35
sv2a ligand (35) 35
biological availability (34) 34
health aspects (34) 34
human immunodeficiency virus--hiv (34) 34
neurosciences (34) 34
seizures (34) 34
biochemistry & molecular biology (33) 33
clinical trials as topic (33) 33
hiv integrase inhibitors - adverse effects (33) 33
kinetics (33) 33
anticonvulsants - pharmacology (32) 32
cross-over studies (32) 32
rats, wistar (32) 32
solubility (32) 32
combination therapy (31) 31
hiv-1 integrase (31) 31
metabolism (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (759) 759
Japanese (11) 11
German (6) 6
Spanish (5) 5
Russian (4) 4
Chinese (3) 3
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Clinical Pharmacology, ISSN 0306-5251, 08/2012, Volume 74, Issue 2, pp. 336 - 345
... of approximately 1.8 log 10  copies ml −1 , and a pharmacokinetic/pharmacodynamic (PK/PD) relationship was identified and characterized. Furthermore, no NNRTI resistance... 
NNRTI | HIV‐1 infection | antiretroviral therapy | drug‐drug interaction | HIV-1 infection | Drug-drug interaction | Antiretroviral therapy | PHARMACOKINETICS | TOLERABILITY | PHARMACOLOGY & PHARMACY | ATAZANAVIR | SIMVASTATIN | drug-drug interaction | PROTEASE INHIBITORS | Fluorobenzenes - pharmacokinetics | Pyrroles - pharmacokinetics | Darunavir | Ethinyl Estradiol - pharmacokinetics | Humans | Pyrrolidinones - pharmacokinetics | Male | Fluorobenzenes - administration & dosage | Indoles - administration & dosage | Lopinavir - pharmacokinetics | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | Drug Interactions | Pyrroles - administration & dosage | Contraceptives, Oral - administration & dosage | Patient Safety | Atazanavir Sulfate | Contraceptives, Oral - pharmacokinetics | Phosphinic Acids - administration & dosage | Raltegravir Potassium | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Risk Assessment | Simvastatin - administration & dosage | Deoxycytidine - administration & dosage | Phosphinic Acids - pharmacokinetics | Rosuvastatin Calcium | Adenine - pharmacokinetics | Sulfonamides - pharmacokinetics | Cross-Over Studies | Cytochrome P-450 CYP3A - metabolism | Atorvastatin | Cytochrome P-450 CYP2D6 - metabolism | Least-Squares Analysis | Lopinavir - administration & dosage | Pyrimidines - pharmacokinetics | Oligopeptides - administration & dosage | Deoxycytidine - analogs & derivatives | Sulfonamides - administration & dosage | Cytochrome P-450 CYP2D6 Inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Heptanoic Acids - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Reverse Transcriptase Inhibitors - pharmacokinetics | Heptanoic Acids - administration & dosage | Female | Ethinyl Estradiol - administration & dosage | Androstenes - pharmacokinetics | Double-Blind Method | Ritonavir - administration & dosage | Pyrimidines - administration & dosage | Oligopeptides - pharmacokinetics | Linear Models | Simvastatin - pharmacokinetics | Androstenes - administration & dosage | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Cytochrome P-450 CYP3A Inhibitors | Ritonavir - pharmacokinetics | Anti-HIV Agents - pharmacokinetics | Indoles - pharmacokinetics | Drug Combinations | Urine | Simvastatin | Drug interactions | Cytochrome P-450 | HIV (Viruses) | Complications and side effects | Analysis | Electrocardiogram | Electrocardiography | DNA polymerases | Ethinyl estradiol | Dosage and administration | EKG | Antiviral agents | Urinalysis | Ritonavir | tenofovir | Cytochrome P450 | Lopinavir | ethinylestradiol | Blood | Infection | non-nucleoside reverse transcriptase inhibitors | Antiviral activity | Drug interaction | Probes | CYP2D6 protein
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 06/2017, Volume 73, Issue 6, pp. 727 - 733
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2014, Volume 58, Issue 3, pp. 413 - 422
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 06/2009, Volume 85, Issue 6, pp. 623 - 627
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 01/2008, Volume 36, Issue 1, pp. 36 - 45
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2009, Volume 53, Issue 7, pp. 2752 - 2755
Journal Article